Longer Repolarization in the Epicardium at the Right Ventricular Outflow Tract Causes Type 1 Electrocardiogram in Patients With Brugada Syndrome

Journal of the American College of Cardiology

Volumn 51, Issue 12, 2008, Pages 1154-1161

  Nagase, Satoshi ^a   Kusano, Kengo Fukushima ^a   Morita, Hiroshi ^a   Nishii, Nobuhiro ^a   Banba, Kimikazu ^a   Watanabe, Atsuyuki ^a   Hiramatsu, Shigeki ^a   Nakamura, Kazufumi ^a   Sakuragi, Satoru ^a   Ohe, Tohru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PILSICAINIDE;

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROGRAPHY; ENDOCARDIUM; EPICARDIUM; EXPERIMENTAL STUDY; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE OUTFLOW TRACT; HUMAN; HYPOTHESIS; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; T WAVE; T WAVE INVERSION; TYPE 1 ELECTROCARDIOGRAM;

ACTION POTENTIALS; ADULT; AGED; BRUGADA SYNDROME; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FEMALE; HEART CONDUCTION SYSTEM; HEART VENTRICLES; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PERICARDIUM; SODIUM CHANNEL BLOCKERS;

EID: 40749160477     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.059     Document Type: Article

References (27)

1. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
2. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111 (2005) 659-670
3. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100 (1999) 1660-1666
4. Antzelevitch C., Brugada P., Brugada J., et al. Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 41 (2003) 1665-1671
5. Antzelevitch C. The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J 22 (2001) 356-363
6. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 29 (2006) 1130-1159
7. Wilde A.A., Antzelevitch C., Borggrefe M., et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 106 (2002) 2514-2519
8. Brugada R., Brugada J., Antzelevitch C., et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101 (2000) 510-515
9. Priori S.G., Napoitano C., Schwartz P.J., et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 102 (2000) 945-947
10. Kurita T., Shimizu W., Inagaki M., et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40 (2002) 330-334
11. Pitzalis M.V., Anaclerio M., Iacoviello M., et al. QT-Interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome. J Am Coll Cardiol 42 (2003) 1632-1637
12. Hevia J.C., Antzelevitch C., Bárzaga F.T., et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 47 (2006) 1828-1834
13. Grant A.O., Carboni M.P., Neplioueva V., et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 110 (2002) 1201-1209
14. Bezzina C., Veldkamp M.W., van Den Berg M.P., et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 85 (1999) 1206-1213
15. Haws C.W., and Lux R.L. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms: effects of interventions that alter repolarization time. Circulation 81 (1990) 281-288
16. Coronel R., de Bakker J.M.T., Wilms-Schopman F.J.G., et al. Monophasic action potentials and activation recovery intervals as measures of ventricular action potential duration: experimental evidence to resolve some controversies. Heart Rhythm 3 (2006) 1043-1050
17. Nagase S., Kusano K.F., Morita H., et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol 39 (2002) 1992-1995
18. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart J 7 (1920) 353-370
19. Hisamatsu K., Morita H., Fukushima Kusano K., et al. Evaluation of the usefulness of recording the ECG in the 3rd intercostal space and prevalence of Brugada-type ECG in accordance with recently established electrocardiographic criteria. Circ J 68 (2004) 135-138
20. Shimizu W., Matsuo K., Takagi M., et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 11 (2000) 396-404
21. Sangwatanaroj S., Prechawat S., Sunsaneewitayakul B., et al. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 22 (2001) 2290-2296
22. Maregalli P.G., Wilde A.A.M., and Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 67 (2005) 367-378
23. Coronel R., Casini S., Koopmann T.T., et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112 (2005) 2769-2777
24. Coronel R., Opthof T., Plotnikov A.N., et al. Long-term cardiac memory in canine heart is associated with the evolution of a transmural repolarization gradient. Cardiovascular Research 74 (2007) 416-425
25. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-295
26. Morita H., Morita S.T., Nagase S., et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 42 (2003) 1624-1631
27. Wu L.M., Orikabe M., Hirano Y., et al. Effect of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells. J Cardiovasc Pharmacol 42 (2003) 410-418